SGL Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
8,197
+251
+3% +$29.4K 0.37% 58
2026
Q1
$884K Buy
7,946
+20
+0.3% +$2.31K 0.33% 65
2025
Q4
$949K Sell
7,926
-664
-8% -$62.3K 0.38% 58
2025
Q3
$709K Buy
8,590
+4,979
+138% +$410K 0.3% 71
2025
Q2
$294K Sell
3,611
-168
-4% -$13.4K 0.14% 107
2025
Q1
$293K Buy
3,779
+838
+28% +$78.2K 0.15% 96
2024
Q4
$252K Buy
+2,941
New +$303K 0.13% 99

Other funds holding MRK

SGL Investment Advisors's MRK Position: Q2 2026 in Review

SGL Investment Advisors increased its Merck (MRK) stake by 3.2% in Q2 2026, buying an estimated $29.4K and bringing the position to 8,197 shares worth $1.07M. The position accounts for 0.37% of the portfolio, ranked #58.

SGL Investment Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • SGL Investment Advisors held 8,197 shares of Merck worth $1.07M as of Q2 2026.
  • SGL Investment Advisors bought 251 Merck shares in Q2 2026, an estimated $29.4K.
  • Merck made up 0.37% of SGL Investment Advisors's portfolio in Q2 2026, its #58 holding.
  • SGL Investment Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on SGL Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.